Gain a better understanding of how including Americans for Ben-Gurion University in your long-term estate planning could benefit you, your family and Ben-Gurion University of the Negev – now and in the future.
Stay up to date on the latest news articles, videos, podcasts, and publications featuring interviews, innovative projects and research, webinars, and more.
Discover how BGU is advancing research in the sciences and the humanities. Bringing together the best and brightest Israeli and international researchers, BGU encourages collaboration and strives for excellence.
Learn about Ben-Gurion University of the Negev, Israel’s most innovative institution of higher learning and research, and how Americans for Ben-Gurion University is helping fulfill David Ben-Gurion’s vision for Israel’s Negev region.
A study conducted by researchers at BGU advises pregnant women to take vitamin supplements containing folic acid as part of their routine pre-natal care.
The Jerusalem Post -- Dr. Yoram Singer and Abu Abod make house calls in unrecognized Bedouin settlements, offering medical care and emotional support to the dying and their families.
Ben-Gurion University of the Negev researcher Dr. Alon Monsonego created a humanized mouse model with a specific gene that responded to A-beta-peptide vaccine, reducing plaque and inflammation.
Baltimore Jewish Times -- With 60 percent of the country's land, but only 10 percent of its population, the Negev, with BGU's help, is a place for pioneers and entrepreneurs who want to make their mark.
Pregnant women have a higher incidence of insufficient amniotic fluid levels (oligohydramnios) in the summer months due to dehydration, according to a study conducted by researchers at Ben-Gurion University of the Negev (BGU).
Jerusalem Post -- BGU researchers discover that teenagers who have a strong social support system are more resilient to depression after being exposed to terrorism-related stress.
Dr. Alon Friedman, a neurosurgeon, professor and researcher at Ben-Gurion University of the Negev, working with researchers from UC Berkeley, California have identified a TGF Beta Blocker that when given to rats prevents epilepsy after brain damage, according to a new study appearing in the July 15 issue of The Journal of Neuroscience.